Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for ferrous sulfate, the active ingredient registered with NAFDAC.
See symptoms on front panel. Relieves hot flashes with headaches *
symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Add the expiry date on your pack for a full Trust Score.
Reasulf Tablets## (duplicate) contains Ferrous sulfate (200 mg), as tablet, according to its NAFDAC registration record.
Yes. Reasulf Tablets## (duplicate) is listed on the NAFDAC register under registration number B4-2517, and its registration is active as of 28 October 2026.
No WHO falsified or substandard medical product alert currently matches Reasulf Tablets## (duplicate) in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number B4-2517, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
See symptoms on front panel. Relieves hot flashes with headaches * (Summarised from the official U.S. FDA label for ferrous sulfate. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.